Project Number 1R43AG069655-01A1 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Development of Aberrant Cdk5 imaging agent for early detection ofAlzheimer's disease pathology and treatment outcome measurement Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 2. Imaging Biomarkers c. PET Other Imaging Researcher and Organization Principal Investigator UPADHYA, SUDARSHAN C Principal Investigator First Name SUDARSHAN C Principal Investigator Last Name UPADHYA Awardee Organization AESTAS PHARMA INC. Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $450,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official LUO, YUAN
